Intracranial Atherosclerosis Disease Associated With Cognitive Impairment and Dementia: Systematic Review and

Behnam Sabayan1,2, Roham Goudarzi3, Yuekai Ji2

  • 1Department of Neurology, Hennepin Healthcare Research Institute Hennepin County Medical Center Minneapolis MN.

Insights

Intracranial atherosclerosis disease (ICAD) is linked to cognitive impairment and dementia. This systematic review confirms the association across diverse populations, highlighting the need for tailored dementia prevention in ICAD patients.

Area of Science:

  • Neurology
  • Cerebrovascular Diseases
  • Cognitive Neuroscience

Background:

  • Intracranial atherosclerosis disease (ICAD) impacts brain blood flow and structure.
  • Existing research on the link between ICAD and cognitive decline presents conflicting findings.
  • A comprehensive review is needed to clarify the association.

Purpose of the Study:

  • To systematically review and synthesize evidence on the relationship between ICAD and cognitive impairment.
  • To evaluate the consistency of findings across different study designs and populations.

Main Methods:

  • A systematic literature search was conducted across major databases (PubMed, EMBASE, PsycInfo, Web of Science) from 2000 to 2023.
  • Included studies were cross-sectional, prospective cohort, and postmortem studies investigating ICAD (≥50% stenosis) and cognitive outcomes.
  • Data from 22 unique studies involving 11,184 individuals were analyzed.

Main Results:

  • A significant association between ICAD and cognitive impairment was found in 70% of cross-sectional and 71% of prospective studies.
  • Pooled analysis revealed ICAD is associated with greater cognitive impairment (OR, 1.87 [95% CI, 1.49-2.35]).
  • Postmortem studies indicated a higher ICAD burden in patients with Alzheimer disease and vascular dementia compared to controls.

Conclusions:

  • Intracranial atherosclerosis disease is significantly associated with cognitive impairment and dementia.
  • This association is consistent across various age, sex, and racial groups.
  • Findings emphasize the importance of personalized dementia prevention strategies for individuals with ICAD.
Abstract

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
498
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
120
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
10
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
197
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
122